Sean Moran Email

Chief Financial Officer . Corbus Pharmaceuticals

Current Roles

Employees:
45
Revenue:
$4.8M
About
Corbus Pharmaceuticals (NASDAQ: CRBP) is a Phase 3, clinical-stage pharmaceutical company focused on advancing the development and commercialization of novel therapies to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Corbus Pharma was named one of the Best Places To Work by Boston Business Journal in 2017. Our people are high-achievers, innovative, creative and, above all else, passionate about what we do in systemic sclerosis, cystic fibrosis, dermatomyositis and systemic lupus eythematosus.
Corbus Pharmaceuticals Address
500 River Ridge Drive
Norwood, MA
United States

Past Companies

Corbus PharmaceuticalsChief Financial Officer
InVivo TherapeuticsChief Financial Officer /Director of Finance
Celsion CorporationChief Financial Officer

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.